Award

Identification and Validation of Clusterin (CLU) Glyco-Biomarkers for Alzheimer’s Disease

Description: Clusterin (CLU) is recognized as the third major risk factor for Alzheimer’s disease (AD), and our research examines how alterations in the sugar structures on the Clusterin protein could signal the disease’s onset and differ between males and females. By employing cutting-edge mapping techniques, we aim to improve early detection and understand the progression of Alzheimer’s. Our goal is to spearhead the development of personalized diagnostic tools and treatments that account for individual biological differences.
Amount: $300,000
Funding type: research
Funder scheme: Alzheimer's Disease Research: Standard
Start date: 2026-07-01
End date: 2029-06-30
Investigator: Qi Zhang (lead)
Institution: Emory University
Funded outputs count: 0
Funder award ID: A2026033S
OpenAlex ID: G9000806615